Author

Fenja Gierschek

Goethe University Frankfurt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Catharina Lahrmann· 1 shared Catherine WölfeliD· 1 shared Daniel SascaiD· 1 shared Evelyn UllrichiD· 1 shared Fédérico MariniiD· 1 shared Hakim EchchannaouiiD· 1 shared Hartmut DöhneriD· 1 shared Jan HabermanniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Catharina Lahrmann

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Menin-Inhibition Sensitizes Acute Myeloid Leukemia to CLEC12A-Directed CAR Cell Therapy

Johanna Rausch, Philipp Wendel, Margarita M. Dzama, Marlene Steiner, Fenja Gierschek, Viktor Fetsch, Lea Rebecca Knapp, Najla Abassi, Marie Kuhmann, Lilian Viehböck, Simon Weisemann, Nadezda Dolgikh, Jan Habermann, Catharina Lahrmann, Matthias Klein, , Michael W.M. Kühn

This paper shows menin inhibitors increase CLEC12A expression in AML, making it more responsive to CLEC12A-targeted CAR T cells, improving treatment outcomes.

bioRxiv · Feb 17, 2026 · PreprintCancer Biology